Table 1.

Laboratory risk factors for thrombosis in 109 women with a history of VTE

Risk factorsAbnormality/totalPercentage
None 39 of 101* 39.0 
Heterozygous factor V:R506Q 38 of 109 35.0  
Homozygous factor V:R506Q 5 of 109 4.6  
Heterozygous G20210A prothrombin 8 of 107 7.5  
Antithrombin deficiency 2 of 109 1.8  
Protein C deficiency 5 of 109 4.6  
Protein S deficiency 5 of 109 4.6  
Hyperhomocystinemia 11 of 101 11.0  
Elevated factor VIII 12 of 102 12.0  
Lupus anticoagulant 3 of 109 2.8  
Of these   
 Two risk factors combined 13 of 101* 13.0  
 Three risk factors combined 3 of 101* 3.0 
Risk factorsAbnormality/totalPercentage
None 39 of 101* 39.0 
Heterozygous factor V:R506Q 38 of 109 35.0  
Homozygous factor V:R506Q 5 of 109 4.6  
Heterozygous G20210A prothrombin 8 of 107 7.5  
Antithrombin deficiency 2 of 109 1.8  
Protein C deficiency 5 of 109 4.6  
Protein S deficiency 5 of 109 4.6  
Hyperhomocystinemia 11 of 101 11.0  
Elevated factor VIII 12 of 102 12.0  
Lupus anticoagulant 3 of 109 2.8  
Of these   
 Two risk factors combined 13 of 101* 13.0  
 Three risk factors combined 3 of 101* 3.0 
*

In 101 women, all risk factors were determined.

Close Modal

or Create an Account

Close Modal
Close Modal